Skip to content

A quasi-randomised pilot study on the efficacy and perceived usefulness of adding chemosignals to mindfulness practice for women with social anxiety.

Emma T Eliasson, Elisa Vigna, Elisa Dal Bò, Cinzia Cecchetto, Letizia Zurlo, Claudio Gentili, Enzo Pasquale Scilingo, Alberto Greco, Fabio Di Francesco, Luca Citi, Nicola Vanello, Johan N Lundström, Gergö Hadlaczky, Vladimir Carli

Scientific Reports September 12, 2025 DOI: 10.1038/s41598-025-18246-w (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Quasi-randomised pilot study Randomized Peer reviewed
Sample size 98
Population Women meeting criteria for Social Anxiety Disorder
Intervention Mindfulness meditation
Duration Two sessions over two consecutive days
Topics Meditation Anxiety
Keywords Chemosignals Olfaction Social anxiety disorder
Key points No significant odour × time interaction effect on state anxiety was found, rejecting the primary hypothesis that emotional body odours enhance mindfulness-induced anxiety reduction.

Abstract

Body odours (BOs) of individuals in specific emotional states can influence receivers' responses - referred to as an emotional contagion. To investigate the potential of BOs to enhance the effects of mindfulness practice, this quasi-randomised pilot study tested the hypothesis that participants exposed to emotional BOs during mindfulness meditation would exhibit a steeper decrease in state anxiety symptoms compared to mindfulness alone (clean air control). Ninety-eight women meeting criteria for Social Anxiety Disorder (SAD) received two mindfulness sessions over two consecutive days, while randomly allocated to one of four conditions: fear BO, joy BO, neutral BO or a clean air control group. No odour × time interaction effect was observed, rejecting the primary hypothesis. Although not statistically significant, effect size estimates suggested a greater reduction in state anxiety for the group receiving fear chemosignals (Day 1 Cohen's d = 0.26, Day 2 Cohen's d = 0.54) compared to the clean air control group. Moreover, the BO groups perceived the mindfulness practice as significantly more helpful compared to the control group (p = 0.002). Given the sample size limits, a larger Randomized Controlled Trial (RCT) incorporating more mindfulness + BO sessions is recommended to further examine the therapeutic potential of human BOs.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics